The outcome of severe Guillain-Barré syndrome after robotic or conventional rehabilitation also depends on the triggering agent and the electrophysiological subtype.

Dear Editor, We read with interest the article by Tramonti et al. about a 54-year-old man with severe Guillain-Barré Syndrome (GBS) following a flu-like infection in April 2022, which required long-term intubation and mechanical ventilation.1 Despite immediate treatment with steroids, Intravenous Immunoglobulins (IVIG), and Plasma Exchange (PE), the patient was discharged to a rehabilitation facility after 9 months with severe quadruparesis and weakness of the axial, respiratory, and pharyngeal muscles.1 After intensive rehabilitation with conventional and robot-assisted approaches, the patient's condition improved significantly after another two months.1 The study is noteworthy, but some points require discussion. [...].